Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $68.96 USD
Change Today +0.28 / 0.41%
Volume 669.1K
PRXL On Other Exchanges
Symbol
Exchange
NASDAQ GS
Stuttgart
As of 8:10 PM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

parexel international corp (PRXL) Key Developments

PAREXEL International Corporation(NasdaqGS:PRXL) added to S&P MidCap 400 Index

PAREXEL International Corporation(NasdaqGS:PRXL) added to S&P MidCap 400 Index

PAREXEL International Corporation(NasdaqGS:PRXL) added to S&P Midcap 400 Sector Indices - Health Care Sector Index

PAREXEL International Corporation(NasdaqGS:PRXL) added to S&P Midcap 400 Sector Indices - Health Care Sector Index

PAREXEL International Corporation(NasdaqGS:PRXL) dropped from S&P SmallCap 600 Index

PAREXEL International Corporation(NasdaqGS:PRXL) dropped from S&P SmallCap 600 Index

PAREXEL International Corporation(NasdaqGS:PRXL) dropped from S&P SmallCap 600 Sector Indices – Health Care Sector Index

PAREXEL International Corporation(NasdaqGS:PRXL) dropped from S&P SmallCap 600 Sector Indices – Health Care Sector Index

PAREXEL International Corporation Launches Next Generation Analytics Capabilities Within Perceptive MyTrials® Platform

PAREXEL International Corporation launched the next generation of its Perceptive MyTrials® platform with advanced analytics capabilities. With the Perceptive MyTrials Analytics solution, clinical trial sponsors can now use a mobile-enabled, single entry-point to access predictive data analytics for multiple studies simultaneously. The solution offers real-time and aggregated analytics allowing sponsors and PAREXEL® clinical research professionals to detect key signals and trends. The Perceptive MyTrials Analytics solution also offers cross-sponsor viewing options for clients who need to evaluate data from multiple sponsors. Developed by PAREXEL Informatics, the Perceptive MyTrials® platform provides an integrated suite of applications for managing clinical trials. Perceptive MyTrials Analytics offers enhanced analytics capabilities and cross-study business intelligence from within the Perceptive MyTrials platform.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PRXL:US $68.96 USD +0.28

PRXL Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Charles River Laboratories International Inc $77.62 USD +3.18
GFK SE €38.73 EUR +0.56
ICON PLC $80.80 USD -0.06
IMS Health Holdings Inc $33.15 USD +1.48
INC Research Holdings Inc $50.03 USD +2.41
View Industry Companies
 

Industry Analysis

PRXL

Industry Average

Valuation PRXL Industry Range
Price/Earnings 25.2x
Price/Sales 1.9x
Price/Book 6.3x
Price/Cash Flow 16.1x
TEV/Sales 1.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PAREXEL INTERNATIONAL CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.